Where does THE University OF Ottawa rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), THE University OF Ottawa ranks #5,042 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does THE University OF Ottawa hold?

THE University OF Ottawa holds 69 US utility patents granted between 2015 and 2025, spanning 62 technology areas.

What is THE University OF Ottawa's Innovation Score?

THE University OF Ottawa has an Innovation Score of 52.0 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE University OF Ottawa focus on?

THE University OF Ottawa's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 20 patents, ranking #754 of 7,863 assignees active in that subclass. Grants appear in 62 CPC subclasses total.

Is THE University OF Ottawa's patent grant rate increasing or decreasing?

THE University OF Ottawa's recent grant velocity is -24% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for THE University OF Ottawa's patents?

THE University OF Ottawa's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the THE University OF Ottawa patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

THE University OF Ottawa

USPTO PatentsView assignee record - 69 granted patents across 62 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, THE ranks #5,042 of 49,997 tracked US assignees by granted-patent volume, with 69 patents across 62 technology areas.

#5,042
of 49,997 US assignees by volume: Top 11%
by Innovation Score (52.0/100): 16.6
avg claims per patent: -24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5042 · Foreign Corporation #5,042 · 69 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 69 grants
UPPER-Q #5,042/49,997
PHOTO-FINISH Sanofi Pasteur
CPC-WIDE G01N · 62 areas
INNOV-PAR 52.0/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -24% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sanofi Pasteur, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How THE’s 52.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.7 pts (28%) Velocity 2.4 pts (5%) Breadth 25.0 pts (48%) Claim depth 9.9 pts (19%)

Qualcomm Incorporated · highest

85
Advantest Test… · near

52
Chr Hansen HMO · near

52
Latham Pool Products · near

52
THE University OF… · this assignee

52
Unifrax I · near

52
3D Lighting… · lowest

7

What this shows THE's Innovation Score is 52.0/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for THE?

Each dot is one of THE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). THE’s own 16.6 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

THE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How THE's grant cadence moved

Between 2020–2024, THE University OF Ottawa received 29 grants versus 38 in 2015–2019 (-24% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 11 grants and bottomed in 2023 at 1. Lead class G01N accounts for 29% of the portfolio across 62 subclasses. Volume neighbours: Sanofi Pasteur, Inc. (#5,037) and Thoratec Corporation (#5,045).

THE's three-year grant acceleration

From 2019–2021 to 2022–2024, THE University OF Ottawa moved from 25 to 9 grants (0.36x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Sanofi Pasteur

69
Stealth Biotherap…

69
Sun World Interna…

69
THE Asan Foundati…

69
Thyssenkrupp Pres…

69
Tornier

69
Telefónica

69
Thoratec

69
THE University OF… ◀

69

What this shows THE holds 69 patents at rank #5,041, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #5,041 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in THE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for THE, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), THE ranks #754 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Unifrax I LLC 52 Advantest Test Solutions, Inc. 52 Latham Pool Products, Inc. 52 Chr. Hansen HMO GmbH 52

Similar claim depth

Nearest assignees by average claims per patent (16.6 here).

Mastercard ASIA/PACIFIC PTE. Ltd. 16.6 avg Dyax Corp. 16.6 avg Arbor Networks, Inc. 16.6 avg Ultrahaptics IP Ltd 16.6 avg

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE University OF Ottawa patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	7.2%
2016	11	15.9%
2017	9	13.0%
2018	8	11.6%
2019	5	7.2%
2020	10	14.5%
2021	10	14.5%
2022	2	2.9%
2023	1	1.4%
2024	6	8.7%
2025partial year	2	2.9%

Which technologies does THE University OF Ottawa patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 20

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C07D - Heterocyclic Compounds 8

C07C - Acyclic OR Carbocyclic Compounds 7

G02B - Optical Elements, Systems OR Apparatus 6

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

B01D - Separation 5

G02F - Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optical Logic ELEMENTS; Optical ANALOGUE/DIGITAL Converters 5

C07K - Peptides 5

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 4

C25F - Processes FOR THE Electrolytic Removal OF Materials From OBJECTS; Apparatus Therefor 4

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 4

Top 15 of 62 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

THE University OF Ottawa's patent record in context - here's where to go next.

THE University OF Ottawa's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 29% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #5,042 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare THE University OF Ottawa against Sanofi Pasteur, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.